1-3 of 3
Andrew Parker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia

Open Access
Clinical Trials & Observations
Jennifer R. Brown, Bastien Nguyen, Sai Prasad Desikan, Helen Won, Shady I. Tantawy, Samuel C McNeely, Narasimha Marella, Hetal S Randeria, Lauren M Hanson, Andrew Parker, Salome Calado Botelho, Jennifer A. Woyach, Krish Patel, Constantine S Tam, Toby A. Eyre, Chan Y Cheah, Nirav N Shah, Paolo Ghia, Wojciech Jurczak, Minna Balbas, Binoj Chandrasekharan Nair, Paolo B. Abada, Chunxiao Wang, Denise Wang, Lindsey Elizabeth Roeker, Varsha Gandhi, William G. Wierda
Journal: Blood
Blood blood.2024027009.
https://doi.org/10.1182/blood.2024027009
Published: 2025
Includes: Supplemental data
Journal Articles

A Phase 1/2 Study of STP938, a First in Class Inhibitor of CTP Synthase 1, in Patients with Relapsed/Refractory B or T Cell Lymphoma

Free
Philip Beer, Maureen Higgins, Hélène Asnagli, Eef Hoeben, Michael Hubank, Andrew Parker, Brian Schwartz
Journal: Blood
Blood (2022) 140 (Supplement 1): 12027–12028.
https://doi.org/10.1182/blood-2022-159963
Published: 2022
Journal Articles

CTPS1 Is a Novel Therapeutic Target in Multiple Myeloma That Synergizes with Inhibition of ATR, CHEK1 or WEE1

Free
Christina Pfeiffer, Alexander Michael Grandits, Hélène Asnagli, Anja Schneller, Julia Huber, Niklas Zojer, Martin Schreder, Andrew Parker, Arnold Bolomsky, Philip Beer, Heinz Ludwig
Journal: Blood
Blood (2022) 140 (Supplement 1): 7088–7089.
https://doi.org/10.1182/blood-2022-160333
Published: 2022